A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
The Fed Won’t Talk About Rate Cuts. Why Traders Are Betting on Them.
2023-11-28 19:45
A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
You Might Like...
Kai Cenat: Exploring Twitch king's top 5 celebrity collaborations during livestreams
Where barbershops are a community hub, he's filling them with books to help young boys find excitement in reading
US FCC proposes to force cable TV operators to disclose full pricing
Taiwan chip giant sees no production hit from China curb on rare metals
Online misinformation runs rampant during coup attempt in Russia
Threads active users have halved in a week, report says
Sony's PSVR 2 is marginally outselling the original headset
Tokens delisted, exchange closed following SEC crypto lawsuits